Chicago, IL, United States of America

Kenneth P Spina

This inventor holds 3 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1991-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 1991-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Kenneth P. Spina

Introduction

Kenneth P. Spina is a notable inventor based in Chicago, IL, with a focus on pharmaceutical innovations. He holds a total of 3 patents, showcasing his contributions to the field of medicine and drug development.

Latest Patents

Among his latest patents are significant advancements in the pharmaceutical industry. One of his notable inventions includes tricyclic erythromycin derivatives, which are compounds or pharmaceutically acceptable salts and esters thereof. Additionally, he has developed angiotensin II receptor antagonists, which are compounds disclosed having a specific formula where the substituents are defined. These compounds play a crucial role in the treatment of various medical conditions.

Career Highlights

Kenneth P. Spina is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Throughout his career, Kenneth has collaborated with esteemed colleagues, including Saul H. Rosenberg and Ly Tam Phan. These collaborations have further enhanced his innovative capabilities and have led to significant advancements in their respective fields.

Conclusion

Kenneth P. Spina's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to impact the field positively, paving the way for future advancements in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…